Tramadol Hydrochloride
Product Images NDC 45865-900

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 45865-900). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (900)

TRAMADOL HCL ER TABLETS 200MG packaging label for the generic version of Ultram ER by Medsource Pharmaceuticals. The label shows key details including dosage strength (200 mg), tablet description (white, round), quantity (#30), and instructions to take one tablet every few hours as needed for pain. It warns about dizziness or drowsiness and advises avoiding alcohol. The label includes federal law restrictions and manufacturer location in India.*

FDA Label Image

Tramadol-figure1 (Tramadol Figure1)

A pharmacokinetic graph comparing Tramadol Hydrochloride Extended-Release Tablets, 200 mg once daily, and Tramadol Immediate-Release (IR) Tablets, 50 mg every six hours. The y-axis shows tramadol concentration in ng/mL, and the x-axis shows time in hours over a 24-hour period, illustrating differences in drug concentration profiles between the two formulations.*

FDA Label Image

Tramadol-figure2 (Tramadol Figure2)

A line graph comparing M1 concentration (ng/mL) over 24 hours for Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol IR Tablets 50 mg every 6 hours. The x-axis represents time in hours, and the y-axis shows concentration in ng/mL. Two lines with different markers illustrate concentration trends for each formulation.*

FDA Label Image

Tramadol-figure3 (Tramadol Figure3)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing percent of patients achieving various response thresholds (percent improvement from baseline) on the x-axis versus percent of patients achieving response on the y-axis. The graph compares responses for Tramadol Hydrochloride Extended-Release Tablets at 100mg, 200mg, 300mg, and 400mg doses, as well as placebo, with trends showing decreasing response percentages as thresholds increase.*

FDA Label Image

Tramadol-figure4 (Tramadol Figure4)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis' showing the percent of patients achieving response at various percent improvement thresholds from baseline. The graph compares Tramadol Hydrochloride Extended-Release Tablets and placebo across a response threshold range from 0 to 100 percent.*

FDA Label Image

Tramadol-structure (Tramadol Structure)

Chemical structure diagram of Tramadol Hydrochloride, showing its molecular arrangement including a cyclohexane ring bonded to a dimethylamino methyl group and a methoxyphenol moiety, with the hydrochloride indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.